Compare LLY & JPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LLY | JPM |
|---|---|---|
| Founded | 1876 | 1799 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 950.7B | 816.0B |
| IPO Year | 2007 | N/A |
| Metric | LLY | JPM |
|---|---|---|
| Price | $985.50 | $288.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 13 |
| Target Price | ★ $1,174.53 | $333.31 |
| AVG Volume (30 Days) | 2.8M | ★ 8.5M |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | 0.70% | ★ 2.04% |
| EPS Growth | ★ 95.99 | N/A |
| EPS | ★ 22.95 | N/A |
| Revenue | ★ $65,179,000,000.00 | N/A |
| Revenue This Year | $27.04 | $16.84 |
| Revenue Next Year | $16.26 | $3.60 |
| P/E Ratio | $42.77 | ★ $15.42 |
| Revenue Growth | ★ 44.70 | N/A |
| 52 Week Low | $623.78 | $202.16 |
| 52 Week High | $1,133.95 | $337.25 |
| Indicator | LLY | JPM |
|---|---|---|
| Relative Strength Index (RSI) | 41.56 | 35.54 |
| Support Level | $766.48 | $282.27 |
| Resistance Level | $1,102.49 | $298.85 |
| Average True Range (ATR) | 27.26 | 7.35 |
| MACD | -4.56 | -1.25 |
| Stochastic Oscillator | 21.45 | 18.13 |
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with more than $4.4 trillion in assets. It is organized into four major segments: consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates and is subject to regulation in multiple countries.